<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01612065</url>
  </required_header>
  <id_info>
    <org_study_id>2752012</org_study_id>
    <nct_id>NCT01612065</nct_id>
  </id_info>
  <brief_title>Optimum Misoprostol Dose Prior to Office Hysteroscopy</brief_title>
  <official_title>The Optimum Dose of Vaginal Misoprostol Prior to Office Hysteroscopy: Double Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <brief_summary>
    <textblock>
      Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal
      route is the best, optimum dose not yet known.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will compare between 2 different doses of vaginal misoprostol, group (1)
      200 ug, group (2) 400 ug, 3hours prior to office hysteroscopy , Infertile patient, patients
      with abnormal bleeding and patient with recurrent abortion Outcome measure: pain score,
      easiness of the procedure, procedure time, complications
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>1year</time_frame>
    <description>Pain score by VAS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Easiness</measure>
    <time_frame>1year</time_frame>
    <description>ease of entry of the office hysteroscopy into the cervix recorded on a 5-point Likert scale: very difficult= 1, difficult = 2, fair = 3, easy = 4, and very easy = 5;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the procedure</measure>
    <time_frame>1year</time_frame>
    <description>Duration of hysteroscopy in seconds</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Infertility</condition>
  <condition>Abnormal Uterine and Vaginal Bleeding, Unspecified</condition>
  <condition>Recurrent Abortion</condition>
  <arm_group>
    <arm_group_label>Misoprostol vaginally, 200 ug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 ug misoprostol in the posterior vaginal fornix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Misoprostol vaginally, 400ug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Misoprostol in the posterior vaginal fornix</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>200 ug</description>
    <arm_group_label>Misoprostol vaginally, 200 ug</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>Misoprostol vaginally, 400 ug</description>
    <arm_group_label>Misoprostol vaginally, 400ug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patient pre- or postmenopausal undergo office hysteroscopy.

          -  Age: from 20 to 60.

          -  BMI between 18 and 30.

        Exclusion Criteria:

          -  PID or

          -  Heavy uterine bleeding

          -  Cervical malignancy.

          -  Symptoms suggestive of endometriosis .

          -  Any cervical abnormality such as pinhole cervix that would obviate passage of a
             catheter through the cervix.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waleed El-khayat, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasr alainy hospital, faculty of medicine , Cairo university</name>
      <address>
        <city>Cairo</city>
        <zip>12211</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2012</study_first_submitted>
  <study_first_submitted_qc>June 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2012</study_first_posted>
  <last_update_submitted>April 10, 2013</last_update_submitted>
  <last_update_submitted_qc>April 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Waleed El-khayat</investigator_full_name>
    <investigator_title>Assistant professor of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>Office hysteroscopy</keyword>
  <keyword>Cervical priming</keyword>
  <keyword>Misoprostol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Abortion, Habitual</mesh_term>
    <mesh_term>Metrorrhagia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

